Release Date: 15/11/10 10:12 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 23.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%